エピソード
-
In the latest episode of The Line Podcast, recorded on July 17th, 2026, Matt Gurney and Jen Gerson keep things refreshingly brief as both are juggling family matters. They begin with Jen's unsuccessful attempt to achieve cottage zen, as she unloads on the latest complaints from American politicians about wildfire smoke drifting south from Canada. Both hosts independently arrive at the same tongue-in-cheek solution: if the Americans don't stop griping, Canada should simply schedule its forest fires for days when the wind is blowing south. (They're kidding. Mostly.) They also discuss Donald Trump's latest bizarre speech and the increasingly revealing comments from senior U.S. officials, who seem unable to hide just how much Prime Minister Mark Carney has gotten under their skin.
This episode is brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage. Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness’ in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how. Find them Fractional-Execs.ca.Your hosts then turn to the slow-burning civil war within Canadian conservatism. Jen, still falling well short of cottage zen, has a few things to say. Matt observes that while Carney may be a practicing Catholic, he also seems to have accumulated an extraordinary amount of good karma in previous lives — politically speaking, he's facing remarkably little effective opposition from either the left or the right. Matt also warns the Conservatives that, whether they realize it or not, they're in danger of getting "Jagmeet Singhed." And it's not subtle.
This episode is also brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network focused on cutting-edge cancer immunotherapy research that they’re helping Canadian researchers bring from labs to patients in clinical trials –– all in Canada.
A new treatment for your cancer has been approved. Can you get it? Maybe, maybe not. Canada isn’t just one health jurisdiction. At the federal level, Health Canada assesses the safety and efficacy of all drugs and therapies in the country, and in a year — sometimes less — they can approve one for sale in Canada. Once approved, — or sometimes while the assessment is happening— the drug’s cost effectiveness is evaluated by Canada’s Drug Agency.
Then the ball goes to the provinces. They work together to negotiate prices with the drug maker, to confirm that it doesn’t duplicate something they’re already stocking, and that its potential value justifies its cost. Only after that can it be provided by each province’s ministry of health. This process can take years. It’s one reason that Canadian innovations leave the country to be developed elsewhere, and why drug companies don’t always choose Canada to initially to launch their products. In the U.S., they get FDA approval, set a price, and wait for the market to decide if the price is right. In Canada, Heath Canada approves and lengthy negotiations start, with no revenue or guarantee of future approval.
Organizations like BioCanRx are willing to wait out the dry years because they’re not-for-profit, but companies with shareholders might skip the Canadian market until they’re making big money elsewhere. This means Canadians have to wait on the system for drugs that could save them, and are saving people in other countries. We’ll talk more about these problems in the weeks to come. Stay tuned for more.
The hosts wrap up by discussing Naheed Nenshi's apology for speaking with an Israeli, which Matt suggests has elevated the Alberta NDP leader to full windbag status. Matt reminds Jen that he used to complain Nenshi needed to get himself into the public eye more often. After this week, he'd like to politely withdraw that recommendation. Jen wonders if maybe this is why he's been invisible — he might just actually be awful at this. Anyway, congrats to Danielle Smith. At this rate, she'll be premier for life.
All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca, and keep your kindling and torches ready. Wait for the code word.
#TheLinePodcast
#MarkCarney
#CanadianPolitics
#DonaldTrump
#CanadaUSRelations
#ConservativeParty
#NaheedNenshi
#AlbertaPolitics
#PoliticalAnalysis
#CurrentAffairs -
In this episode of On The Line, host Matt Gurney sits down with Reece Martin, transit and transportation expert and new media entrepreneur, for a conversation about infrastructure, public policy, and how an online passion project turned into a career.
This episode is brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network focused on cutting-edge cancer immunotherapy research that they’re helping Canadian researchers bring from labs to patients in clinical trials –– all in Canada.
A new treatment for your cancer has been approved. Can you get it? Maybe, maybe not. Canada isn’t just one health jurisdiction. At the federal level, Health Canada assesses the safety and efficacy of all drugs and therapies in the country, and in a year — sometimes less — they can approve one for sale in Canada. Once approved, — or sometimes while the assessment is happening— the drug's cost effectiveness is evaluated by Canada's Drug Agency.
Then the ball goes to the provinces. They work together to negotiate prices with the drug maker, to confirm that it doesn't duplicate something they’re already stocking, and that its potential value justifies its cost. Only after that can it be provided by each province’s ministry of health. This process can take years. It’s one reason that Canadian innovations leave the country to be developed elsewhere, and why drug companies don’t always choose Canada initially to launch their products. In the U.S., they get FDA approval, set a price, and wait for the market to decide if the price is right. In Canada, Health Canada approves and lengthy negotiations start, with no revenue or guarantee of future approval.
Organizations like BioCanRx are willing to wait out the dry years because they're not-for-profit, but companies with shareholders might skip the Canadian market until they’re making big money elsewhere. This means Canadians have to wait on the system for drugs that could save them, and are saving people in other countries. We’ll talk more about these problems in the weeks to come. Stay tuned for more.
Martin explains how his fascination with transit and transportation grew into a successful YouTube channel, and how that work eventually made him a go-to commentator for conventional media on major infrastructure issues. They discuss the opportunities created by the new media landscape, the challenges of building an audience around complex policy topics, and why expertise can now emerge from outside traditional institutions.
From there, the conversation turns to Canada’s infrastructure record. Matt and Jen often joke that “Canada no build good,” and Martin largely agrees — but with important caveats. He explains where Canada consistently goes wrong, why projects take so long and cost so much, and how political incentives often work against good long-term planning.
This episode is also brought to you by the Forest Products Association of Canada. Canada’s forest products sector is not asking Ottawa to start over. The federal government has heard the advice. It has recognized the challenges. And it has put a plan on the table. Now the test is action.
That means clearing made-in-Canada barriers: regulatory duplication, transportation bottlenecks, and uncertainty around predictable access to manage our forests. It means working with provinces to protect communities from wildfire risk and giving companies the confidence to invest here at home. Nearly 200,000 Canadians working in this sector are looking for results.
The playbook is written. Now Ottawa needs to deliver. Learn more at fpac.ca.
At the same time, Martin argues that Canada has real infrastructure success stories that deserve more attention. Rather than assuming failure is inevitable, governments should study the jurisdictions that consistently deliver major projects on time and on budget, both at home and abroad. If Canada can learn those lessons — and avoid the kinds of procurement failures that have plagued everything from pipelines to military equipment — our cities could finally get the transit systems they need.
And yes, that conversation inevitably leads to the question every Canadian transit enthusiast eventually asks: will Canada actually build true high-speed rail?
Be still, our beating hearts. Check out our main page at ReadTheLine.ca, and be sure to check out and follow Reece's YouTube channel and Substack, as well.
This episode is also brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That’s why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.
To learn more, visit ap1000.cameco.com.
YOUTUBE: https://www.youtube.com/c/RMTransit/videos
SUBSTACK: https://www.thetransitbrief.net/
-
エピソードを見逃しましたか？
-
In the latest episode of The Line Podcast, recorded on July 10, 2026, Matt Gurney and Jen Gerson begin with a discussion of a recent Wall Street Journal piece highlighting Prime Minister Mark Carney’s role in pulling Europe back toward a more realistic strategic footing and away from its longstanding dependence on the United States. Canada, and Carney in particular, appear to be taking an unexpectedly prominent leadership role. Your hosts wonder what Washington’s response will be, and whether the White House will decide that Canada needs to be reminded who’s boss.
This episode is brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.
Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness’ in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.
Find them Fractional-Execs.ca.
Next, they turn to the proposed Canadian Shield pipeline. On strictly commercial grounds, the project may not make much sense. But Matt and Jen argue that economics may no longer be the primary point. The proposal sends a signal that Canada is prepared to build the infrastructure needed to stand more independently if circumstances require it. That message has value all on its own. As Matt puts it, borrowing from the movie Contact: “Why build one when you can build two at twice the price?”
This episode is brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network bringing cutting edge cancer immunotherapy research from Canadian labs to patients in clinical trials –– all in Canada.
A drug that can treat your cancer is being tested in a Canadian clinical trial, but can you access it? Depends — where do you live? Clinical trials taking place in Canada usually open sites in major centers with research hospitals. Smaller hospitals face many challenges including having enough know-how to deliver experimental therapies, and administrative, legal, and regulatory responsibilities that come with a trial. There are also data and interoperability issues at hospitals that don’t routinely participate in research.
So if you don’t live in a major centre, participating in the trial requires you to relocate there for the duration of treatment –– the cost of the treatment is covered, but the cost of being in the city where it happens is your responsibility. Patient advocacy groups might be able to help with some of those expenses, but this obviously can be a barrier for a lot of Canadians.
A therapy might only become available to everyone across Canada if a trial is successful and the drug is approved –– but not necessarily, and maybe not anytime soon. More on that next time. Visit BioCanRx.com to learn more.
Finally, the thoroughly hungover shell of Jen Gerson emerges from ten straight days of Calgary Stampede festivities with a political field report. Beneath the parties and pancake breakfasts, she says, the fractures within Canadian conservatism are becoming impossible to ignore. It’s increasingly obvious who is and isn’t willing to speak to whom. What should have been an outstanding month for Alberta Premier Danielle Smith has instead been overshadowed by self-inflicted drama. Meanwhile, Conservative leader Pierre Poilievre continues to struggle against political newcomer Carney. It’s a remarkable — and, in many ways, surprising — dynamic to watch. Wasn't Poilievre supposed to be the political pro who'd mop the floor with the rookie Euro banker? Guess not!
All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca and, always and forever, like and subscribe.
Programming note: The Line is taking a two-week summer holiday. The podcasts will continue, but barring major news events, our page will be quiet for a few weeks. We need a break!
#TheLinePodcast
#MarkCarney
#CanadianPolitics
#CanadaUSRelations
#PipelinePolitics
#DanielleSmith
#PierrePoilievre
#CalgaryStampede
#Geopolitics
#CurrentAffairs -
In this episode of On The Line, host Jen Gerson is joined by Andrew Leach, noted energy and environmental economist and professor of economics and law at the University of Alberta, for a conversation about Canadian energy policy at a pivotal moment.
This episode is brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network bringing cutting edge cancer immunotherapy research from Canadian labs to patients in clinical trials –– all in Canada.
A drug that can treat your cancer is being tested in a Canadian clinical trial, but can you access it? Depends — where do you live? Clinical trials taking place in Canada usually open sites in major centers with research hospitals. Smaller hospitals face many challenges including having enough know-how to deliver experimental therapies, and administrative, legal, and regulatory responsibilities that come with a trial. There are also data and interoperability issues at hospitals that don't routinely participate in research.
So if you don’t live in a major centre, participating in the trial requires you to relocate there for the duration of treatment –– the cost of the treatment is covered, but the cost of being in the city where it happens is your responsibility. Patient advocacy groups might be able to help with some of those expenses, but this obviously can be a barrier for a lot of Canadians.
A therapy might only become available to everyone across Canada if a trial is successful and the drug is approved –– but not necessarily, and maybe not anytime soon. More on that next time. Visit BioCanRx.com to learn more.
Recorded on July 2, 2026, just ahead of two major pipeline announcements, the discussion doesn’t cover the specifics of the federal government’s decision to retrace the TMX route or the proposed Canadian Shield pipeline between Alberta and Sarnia. Instead, Gerson and Leach focus on the broader forces shaping Canada’s energy future.
They discuss Prime Minister Mark Carney’s latest Forward Guidance video, the influence of the United States on Canadian energy policy and markets, the promise and limitations of carbon capture and storage, and the political significance of the new Memorandum of Understanding between Alberta and Ottawa. Throughout the conversation, Leach offers his perspective on what has changed — and what hasn’t — in the relationship between governments, industry, and the public.
This episode is also brought to you by the Forest Products Association of Canada. Canada’s forest products sector is not asking Ottawa to start over. The federal government has heard the advice. It has recognized the challenges. And it has put a plan on the table. Now the test is action.
That means clearing made-in-Canada barriers: regulatory duplication, transportation bottlenecks, and uncertainty around predictable access to manage our forests. It means working with provinces to protect communities from wildfire risk and giving companies the confidence to invest here at home. Nearly 200,000 Canadians working in this sector are looking for results.
The playbook is written. Now Ottawa needs to deliver. Learn more at fpac.ca.The episode also asks a larger question: after decades of political conflict over pipelines, is Canada finally entering a new era? Could this be the beginning of a more grounded conversation about the country’s oil and gas sector, one that focuses less on symbolic battles and more on practical questions of economics, infrastructure, and national interest?
This episode is also brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That’s why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.
To learn more, visit ap1000.cameco.com.
If you enjoyed the episode, be sure to share it, and as always, like and subscribe to us on your podcast or video app of choice. Be sure to check out our main page at ReadTheLine.ca.
#OnTheLine #AndrewLeach #Energy #Pipelines #TMX #OilAndGas #MarkCarney #Alberta #CanadaPolitics #JenGerson
-
In the latest episode of The Line Podcast, recorded on July 3rd, 2026, Matt Gurney and Jen Gerson begin with the biggest political news of the week: a pipeline deal. Prime Minister Mark Carney has struck agreements with both Alberta and British Columbia to move another pipeline project forward. Your hosts discuss the proposed route, which closely follows the existing Trans Mountain corridor, the political wheeling and dealing that made the agreement possible, and what it could mean for Alberta’s upcoming referendum. Matt also can’t help asking an obvious question: since this was always the logical outcome, why did it take so long? Was there a genuine engineering obstacle behind the scenes, or are Canadian governments simply incapable of moving quickly?
This episode is brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.
Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness’ in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.
Find them Fractional-Execs.ca.
Next, they turn to another round of comments from U.S. Ambassador Pete Hoekstra. After a brief discussion of CUSMA, the conversation shifts to Hoekstra’s remarks about the Gordie Howe International Bridge. Your hosts aren’t especially worried. In fact, they think they have the perfect strategy: troll the White House until it becomes so embarrassed that it can’t wait to open the bridge just to make the pain stop. Their suggestions include live episodes of The View from the bridge deck, Bruce Springsteen concerts, and, naturally, renaming it the Barack Hussein Obama Nobel Peace Prize Bridge of Friendship.
This episode is also brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network focused on cutting-edge immunotherapy research that they’re helping Canadian researchers bring from labs to patients in clinical trials –– all in Canada.Clinical trials are the way new drugs, including immunotherapies, are tested in patients around the world. Health Canada, our national regulator, reviews and approves all Clinical Trial Applications, or CTAs, returning a decision within 30 days –– a similar turnaround time as the US FDA and other major jurisdictions. To submit a complete CTA, applicants need to provide hundreds –– sometimes thousands –– of pages of data showing that a drug has a compelling chance of providing benefit, that it can be manufactured consistently, and that it’s safe to administer to trial participants. This is especially hard for Canadian researchers because scientific studies that generate the necessary data aren't supported by many federal grants, which usually prioritize originality over real world impact. BioCanRx helps Canadian researchers succeed in the CTA process, and so far they’ve gotten 16 therapies to trial. To learn more, visit BioCanRx.com.Finally, Matt attempts to diagnose what has gone wrong with Canada’s civic culture and even ventures a possible cure. Toronto, he argues, needs its own version of the Calgary Stampede, and Canada more broadly needs something capable of genuinely uniting the country. The trouble is that neither host can think of an obvious candidate. They conclude that Canada — and Toronto in particular — has become too self-conscious and too embarrassed by its own past to celebrate it with much enthusiasm.
All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca.
#TheLinePodcast
#MarkCarney
#PipelinePolitics
#CanadianPolitics
#CanadaUSRelations
#CUSMA
#GordieHoweBridge
#AlbertaPolitics
#PoliticalAnalysis
#CurrentAffairs -
In this episode of On The Line, host Matt Gurney sits down with Dr. Brian Goldman, veteran emergency physician at Mount Sinai Hospital in Toronto and author of The Casino Shift: Stories from an ER on the Edge, for a candid conversation about the state of emergency medicine in Canada. (You can find it on Indigo's website, or, if you prefer, on Amazon.)
This episode is brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network bringing cutting edge cancer immunotherapy research from Canadian labs to patients in clinical trials –– all in Canada.Clinical trials are the way new drugs, including immunotherapies, are tested in patients around the world. It’s up to the developer of the drug to decide whether they want to trial it in Canada –– and many do. Health Canada, our national regulator, reviews and approves all Clinical Trial Applications, or CTAs, returning a decision within 30 days –– a similar turnaround time as the U.S. FDA and other major jurisdictions. If they approve, and if the trial receives research ethics approval, it can start enrolling Canadian patients. To submit a complete CTA, applicants must provide hundreds –– sometimes thousands –– of pages of data showing that a drug has a compelling chance of providing benefit, that it can be manufactured consistently, and that it’s safe to administer to trial participants.This is especially hard for Canadian researchers because scientific studies that generate the necessary data aren't supported by many federal grants, which usually prioritize originality over real-world impact. BioCanRx helps Canadian researchers succeed in the CTA process, and so far they’ve gotten 16 therapies to trial.But once a trial starts, how can Canadians learn about it, and where can they access it? That question and more next time. Visit BioCanRx.com to learn more.Drawing on decades in one of the country’s busiest emergency departments, Goldman explains why today’s ERs are under extraordinary strain, and why the problems extend far beyond long wait times. They discuss the pressures facing doctors, nurses, and patients alike, the growing mismatch between demand and capacity, and why the old problem of hallway medicine is increasingly giving way to something even worse: chair medicine, with patients waiting for hours in chairs because there simply isn’t anywhere else to put them.
The conversation also explores the human side of emergency medicine. Goldman reflects on the emotional and psychological toll of working in an overwhelmed system, the stories that inspired The Casino Shift, and what keeps health-care workers coming back despite the mounting pressures.
This episode is also brought to you by the Forest Products Association of Canada. A stronger forest industry can help build Canada strong. We need more homes, faster and more affordably, and Canadian wood can be part of the solution. Light-frame construction, mass timber, modular systems, and other modern building methods can support housing, lower embodied carbon, and strengthen domestic supply chains. The same opportunity exists in schools, health facilities, community buildings, and public infrastructure. When Canada builds, Canadian materials and Canadian workers must be part of the plan. Learn more at fpac.ca.Finally, Matt and Goldman tackle one of the most contentious questions in Canadian health care. Goldman argues that it’s time for a calm, respectful, and evidence-based discussion about whether private options should play a larger role within Canada’s publicly funded system. Rather than treating the issue as ideological warfare, he makes the case for focusing on what actually improves patient care, and how other jurisdictions are approaching this problem.
It’s a frank discussion about the realities facing Canada’s healthcare system, the people trying to hold it together, and the difficult choices that may lie ahead.
This episode is also brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That’s why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.
To learn more, visit ap1000.cameco.com.
If you enjoyed the episode, be sure to share it, and as always, like and subscribe to us on your podcast or video app of choice, and check out our main page at ReadTheLine.ca.
#OnTheLine #BrianGoldman #Healthcare #EmergencyMedicine #CanadianHealthcare #MountSinai #TheCasinoShift #PublicHealth #CanadaPolitics #MattGurney
-
In today’s episode of The Line Podcast, recorded on June 26th, 2026, Matt Gurney and Jen Gerson begin with a rare moment of joy. After decades of delay and political paralysis, there is finally a plan to deal with 24 Sussex Drive. Your hosts don’t love every aspect of it, but they’re so relieved that someone has finally decided to do something that they’re prepared to celebrate. Now comes the hard part: not finding a way to mess it up.
This episode of The Line Podcast is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That’s why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers. To learn more, visit ap1000.cameco.com.From there, they turn to the tragic shooting in Montreal that claimed the life of another police officer. Beyond the immediate heartbreak, your hosts focus on two broader issues. First, they argue that the media should have published the shooter’s manifesto. By choosing not to do so, they contend, some early reporting ended up being incomplete or inaccurate. Second, they discuss the rush by commentators across the political spectrum to comb through the manifesto looking for evidence that the attacker perfectly represented their opponents — or, failing that, had nothing whatsoever to do with their own side. Matt and Jen argue that modern terrorism is often ideologically incoherent, and that treating every attack as an opportunity for partisan point-scoring will only make it harder to understand and prevent future violence.
This episode is also brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.
Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness’ in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.
Find them Fractional-Execs.ca.
Finally, Jen makes a wardrobe change that only video viewers will fully appreciate before walking Matt through the increasingly strange politics of the Calgary Stampede. What was once simply Alberta’s biggest annual celebration is now becoming another front in an ongoing proxy war between competing factions within the broader conservative movement.
This episode is also brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network, which helps bring cutting edge cancer immunotherapy research from Canadian scientists from labs to patients in clinical trials –– all in Canada. Cancer is very good at evading your immune system. But in some tumors, researchers find cancer-killing immune cells called tumour infiltrating lymphocytes, or TILs. They get inside the tumour and start fighting — but they’re outnumbered and ill equipped. Researchers in Canada and around the world are studying techniques to extract them from a tumour and multiply them in a lab. Once they number in the millions, they’re injected back into the tumour to do more damage. Research into this line of attack against cancer is ongoing. There are plenty of unanswered questions, and we're working hard to answer them. Learn more about this and other critical work at BioCanRx.com.All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca, and as ever, like and subscribe.
#TheLinePodcast
#CanadianPolitics
#24Sussex
#Montreal
#CalgaryStampede
#AlbertaPolitics
#PoliticalAnalysis
#CanadianMedia
#LawEnforcement#CurrentAffairs
-
In today’s episode of On The Line, host Matt Gurney is joined by two guests for conversations about housing, politics, and why governments sometimes struggle to explain themselves.
This episode is brought to you by BioCanRx. When your immune system recognizes that cancer is a problem, but can’t kill it, can science help? This summer we’re partnering with BioCanRx, a federally-funded Canadian not-for-profit research network, to learn about cutting edge cancer immunotherapy research that they’re helping Canadian researchers bring from labs to patients in clinical trials –– all in Canada.
One of the reasons cancers are so destructive is because they find ways to evade your immune system. But in some tumours, researchers find cancer-killing immune cells called "tumour infiltrating lymphocytes," or TILs. These are like infantry grunts choosing to stand their ground during the final fight in a superhero movie. They get inside the tumour and start fighting – –but they’re outnumbered and ill equipped. They need reinforcements.
Researchers in Canada and around the world are studying techniques to extract them from a tumour and multiply them in a lab environment. Once they number in the millions, they're sent back into the fight. Research into this line of attack against cancer is ongoing, and there are plenty of questions — we'll be covering more of them over the course of the summer. Go to BioCanRx.com to learn more about these new ways of fighting cancer.First up is Mike Moffatt of the Missing Middle Initiative and co-host of the Missing Middle Podcast. He joins Matt to discuss the much-debated “condo bailout” and why, despite the label, it isn’t actually a condo bailout at all. Moffatt argues that the government has done itself no favours by communicating the policy so poorly, and walks listeners through what the plan is — and what it isn’t. The conversation then broadens into a look at the state of housing in Canada more generally. There are some signs of progress, but the underlying challenges remain enormous, and Moffatt explains why solving them will require much more than a handful of headline-grabbing announcements.
This episode is also brought to you by the Forest Products Association of Canada. A stronger forest industry depends on getting goods to market. Forest products move by truck, rail, and ship, and reliability matters. When costs rise or shipments stall, mills, workers, customers, and communities all feel the impact. Stronger trade corridors, better rail performance, labour stability, and reliable transportation should be treated as core parts of Canada’s productivity agenda. For a sector rooted in communities and connected to global markets, transportation is transformation. Learn more at FPAC.ca.
Then Matt is joined by Andrew MacDougall of Trafalgar Strategy for a look across the Atlantic at the increasingly turbulent state of British politics. They discuss the struggles of now-outgoing Prime Minister Keir Starmer, the rise of Andy Burnham as a potential future national leader, and why so many observers now see the United Kingdom as becoming increasingly difficult to govern. MacDougall argues that the country’s problems run deeper than any one politician or party, and offers his own diagnosis of what has gone wrong.
It’s a pair of conversations about institutions under strain, political communication, and the challenge of governing in an era when public patience is increasingly in short supply.
This episode is also brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That’s why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.
To learn more, visit ap1000.cameco.com.Check out our main page at ReadTheLine.ca, and as always, like and subscribe.
#OnTheLine #Housing #MikeMoffatt #MissingMiddle #CanadaHousing #KeirStarmer #AndyBurnham #UKPolitics #AndrewMacDougall #MattGurney
-
In the latest episode of The Line Podcast, recorded on June 19th, 2026, Matt Gurney and Jen Gerson begin with a foreign affairs roundup. Prime Minister Mark Carney heads to Ireland and France to strengthen ties with Europe while also trying to maintain a workable relationship with Donald Trump. Meanwhile, U.S. Defense Secretary Pete Hegseth visits NATO and delivers some pointed criticism of allies that, while not directed at Canada by name, certainly sounds familiar. Your hosts also discuss the aftermath of America’s confrontation with Iran. Matt argues that the United States has, in practical terms, suffered a defeat — an embarrassing outcome for Trump, but perhaps a useful lesson for the rest of us about the limits of military power.
This episode is brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.
Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness’ in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.
Find them Fractional-Execs.ca.Next, they take a quick tour through the provinces. Matt is increasingly worried that Doug Ford could inadvertently throw Canada-U.S. negotiations into chaos, and explains why. Jen provides an update from Alberta, where the political situation remains bizarre. By the end of the segment, both hosts arrive at a grim conclusion: the incentives facing almost every major political actor now reward escalation, confrontation, and nastiness. That rarely ends well.
This episode of The Line Podcast is also brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network helping Canadian researchers bring treatments from labs to patients in clinical trials –– all in Canada.
Every day, your immune system finds and destroys different types of threats –– both external invaders like viruses, and internal dangers like pre-cancerous cells in your own body. But cancer can sometimes evade detection. Researchers are working to identify flags found on cancer cells, called antigens. By training your immune system to recognize these antigens, immunotherapy can help your immune system destroy cancer.
In addition to funding clinical trials, BioCanRx supports research teams who identify these cancer antigens, and find new ways to target them. Many challenges remain — and we’re working on solving them. You’ll hear more over the summer. For now, go to BioCanRx.com to learn more.
Finally, Jen disappears down one of her trademark rabbit holes and emerges with a sweeping explanation of how she came to fully appreciate the sheer economic power of the United States. Somehow, this journey involves gas pumps, brisket, beef jerky, the Soviet Union, and the defeat of Imperial Japan in 1945. Your hosts find themselves reflecting on what American economic dominance really means, why it has proven so durable, and what lessons Canada should draw from it as we navigate an increasingly uncertain world.
All that and more in the latest episode of The Line Podcast. Check us out on our main page, ReadTheLine.ca.
#TheLinePodcast
#MarkCarney
#DonaldTrump
#CanadaUSRelations
#AlbertaPolitics
#DougFord
#CanadianPolitics
#Geopolitics
#NATO
#CurrentAffairs -
In today’s On The Line, host Jen Gerson speaks with Mark Kawar, an amateur historian and journalist whose book America But Bigger explores a surprisingly persistent feature of American history: attempts to expand the United States beyond its current borders.
This episode of On The Line is brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network helping Canadian researchers bring treatments from labs to patients in clinical trials –– all in Canada.
Cancer can hide from your immune system. So how can we target it? Every day, your immune system finds and destroys different types of threats –– both external invaders like viruses, and internal dangers like pre-cancerous cells in your own body. But no system is perfect — sometimes something evades detection. Researchers are working to identify flags found on cancer cells, called antigens. By training your immune system to recognize these antigens as signals for destruction, some forms of immunotherapy equip your immune system to respond to cancer’s asymmetrical threat.
In addition to funding clinical trials, BioCanRx supports research teams who identify cancer antigens, and find new ways to target them with immunotherapies. There’s still a lot to figure out. Can we train the immune system to hit these antigens before cancer takes root? Why do some cancers still manage to evade therapies designed to find their antigens? Many other questions remain — and we’re working on answering them. You’ll hear more over the summer. For now, go to BioCanRx.com to learn more.
Kawar walks Gerson through the long history of American expansionist ambitions, from schemes that never got off the ground to serious efforts that came much closer to success than many people realize. Along the way, he notes that not every annexation proposal was unwelcome to the people being annexed, and that the historical record is often more complicated than simple stories of American aggression.
This episode is also brought to you by the Forest Products Association of Canada. A stronger forest industry means investing in the mills and facilities that anchor communities across Canada. Companies are ready to modernize with cleaner equipment, better energy efficiency, advanced wood products, biomaterials, and smarter use of every part of the tree. These are productive, lower-emission, export-oriented investments. But good projects need a workable business case. Our economy needs practical tools to unlock private capital and keep investment here. Learn more at fpac.ca.
More importantly, Kawar examines why so many of these projects ultimately failed. The United States has often possessed enormous economic, military, and political power, but translating that power into lasting territorial expansion has proven more difficult than many Americans imagined. Again and again, resistance, geography, politics, and simple practicality imposed limits on what even the world’s most powerful country could accomplish.
The result is a fascinating conversation about ambition, empire, national identity, and the often-overlooked constraints on American power. It’s also a discussion that may hold some lessons for Canadians, should they ever find themselves wondering about the limits of U.S. influence. For whatever reason.
This episode is also brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That’s why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.
To learn more, visit ap1000.cameco.com.Visit our main page at ReadTheLine.ca. Be sure to like and subscribe. We’ll be back on Friday with another episode of The Line Podcast.
#Canada #Politics #UnitedStates #Greenland #annexation #51 #51State #OnTheLine
-
In the latest episode of The Line Podcast, recorded on June 12th, 2026, Matt Gurney and Jen Gerson begin with an update from Alberta. Jen reviews Pierre Poilievre’s recent speech on why Alberta belongs in Canada. She liked it, with some caveats. Matt was somewhat more encouraged. He also has a few sharp words for Liberals who seem determined to police the boundaries of acceptable federalism. His view is simple: if people are defending Canada, let them defend Canada. Not every argument for national unity needs to come packaged with Liberal talking points. From Toronto, Matt also reflects on a genuine tragedy this week — a police officer killed in the line of duty while confronting a problem that had been allowed to fester for far too long. It’s difficult to discuss without emotion. In his view, it never should have ended this way. But, alas, it was always going to: even if the exact tragedy was unforeseen, a tragedy was inevitable.
This episode is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That’s why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.
To learn more, visit ap1000.cameco.com.The hosts then take a very different turn. In what may be the strangest segment of the year, Jen reimagines 250 years of Canada-U.S. relations as a raunchy romantic comedy full of love, betrayal, heartbreak, and, yes, sex. Video viewers can watch Matt become increasingly horrified as the bit unfolds — not because he disagrees with the analysis, but because he finds himself unable to refute it.
This episode is also brought to you by BioCanRx, a federally funded, not-for-profit Canadian research network that specializes in bringing Canadian cancer immunotherapy research from the lab all the way to patients in clinical trials in Canada. Immunotherapy is about assisting your immune system in identifying unhealthy cells –– especially cancer –– that have found a way to evade detection. One way researchers are doing this is through something called CAR T. They draw your blood, isolate one type of your immune cells –– T-Cells –– and use a virus to inject genetic instructions that cause them to grow new receptors designed specifically to find and destroy your particular cancer. In one of the 16 trials BioCanRx funds based on Canadian technology, CLIC-01, the median number of months remaining for patients with late-stage leukemia and lymphoma tripled. Some have been cancer free for years.
You’ll hear more over the summer. For now, go to BioCanRx.com to learn moreAfter that, the hosts wrap up with a discussion about children and social media. Both agree that kids probably shouldn’t be spending their lives online. Their concern is that any attempt by the government to solve that problem could easily create several new ones. If recent experience is any guide, they aren’t especially confident Ottawa can regulate this area without making a mess of it.
All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca, and, as ever, like and subscribe.
#TheLinePodcast
#PierrePoilievre
#AlbertaPolitics
#CanadianPolitics
#CanadaUSRelations
#SocialMedia
#Parenting
#NationalUnity
#PoliticalPodcast
#CurrentAffairs -
In this episode of On The Line, host Matt Gurney is joined by two guests for conversations about politics, technology, and trust.
This episode of On The Line is brought to you by BioCanRX, a federally funded, not-for-profit Canadian research network that specializes in bringing Canadian cancer immunotherapy research from the lab all the way to patients in clinical trials in Canada. Can science help your immune system detect and destroy cancer? Immunotherapy is about assisting your immune system in identifying unhealthy cells –– especially cancer –– that have found a way to evade detection. One way researchers are doing this is through something called CAR T. They draw your blood, isolate one type of your immune cells –– T-Cells –– and use a virus to inject genetic instructions that cause them to grow new receptors designed specifically to bind with your particular cancer. When those cells are re-infused into your body, they hopefully will be able to find and destroy your cancer.
The results are promising. In one of the 16 trials BioCanRx funds based on Canadian technology, CLIC-01, the median number of months remaining for patients with late-stage leukemia and lymphoma tripled. For some, the response was even bigger: they went from being out of options to cancer free, and have stayed that way for several years.
Many questions remain — and we're working on answering them. You'll hear more over the summer. For now, go to BioCanRX.com to learn more.First up is PJ Fournier of 338Canada for a look at the latest political numbers. They discuss the good news for Mark Carney, the bad news for Pierre Poilievre, and why the Liberal numbers may not be quite as strong as they first appear. The conversation then turns to Quebec, where the next provincial election is shaping up to be one of the strangest contests either man can remember. Fournier struggles to find a historical comparison. They also discuss softening support for separation in Quebec, how that compares with developments in Alberta, and a point Matt makes that PJ suspects may not be especially popular with Quebec nationalists — even if he doesn’t disagree with it.
Then Matt is joined by David Shipley of Beauceron Security for a discussion about artificial intelligence, social media, and the growing gap between technological change and political institutions. How much of the current AI boom is real, and how much is hype fuelled by companies racing toward public offerings? Shipley argues that Canadians deserve greater transparency around the Tumbler Ridge case, while Matt notes that he can’t even get straightforward answers about transit delays, leaving him less than optimistic about the prospects for accountability.
This episode is also brought to you by the Forest Products Association of Canada. A stronger forest industry starts with predictability. Mill modernization, bioenergy, mass timber, and advanced biomaterials all depend on reliable access to usable Canadian wood fibre, workable timelines, and clear rules. Provinces lead forest management, and the federal role should be coordinated, complementary, and focused on results. Every unnecessary delay makes it harder to keep jobs and attract investment. For a sector rooted in communities, regulatory efficiency is economic policy. Learn more at FPAC.ca.
The conversation also examines how major social media platforms are being exploited for fraud and manipulation, an issue Shipley has been testifying about. The core problem, he argues, is that the internet moves at the speed of light while politicians move at the speed of Parliament. That mismatch is creating vulnerabilities that are only getting worse. The episode closes with a warning to Albertans heading into a possible referendum campaign: Shipley isn’t telling anyone how to vote, but he is urging people to be extremely careful about what they believe online. Foreign interference efforts are already arriving, and they’re unlikely to get less sophisticated from here.
This episode is also brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That’s why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.
To learn more, visit ap1000.cameco.com.Check out our main page at ReadTheLine.ca and be sure to like and subscribe. We’ll be back on Friday with another episode of The Line Podcast.
#OnTheLine #CanadaPolitics #338Canada #PJFournier #MarkCarney #PierrePoilievre #QuebecPolitics #AlbertaPolitics #ArtificialIntelligence #CyberSecurity #DavidShipley #ForeignInterference #MattGurney
-
In the latest episode of The Line Podcast, recorded on June 5th, 2026, Matt Gurney and Jen Gerson begin with reports that Prime Minister Mark Carney has a tendency to raise his voice behind closed doors when dealing with his Liberal caucus. According to reporting in the Toronto Star, the PM may not always be the calm technocrat he appears to be in public. Your hosts cannot endorse a toxic workplace, of course, but they also suspect many Canadians won’t be especially upset by the news. After all, they argue, a lot of voters chose the Liberals out of necessity rather than affection, and more than a few people might conclude that after a decade of terrible Liberal management, the former PM's leftovers deserve a real chewing out.
This episode is brought to you by the Forest Products Association of Canada. Canada’s forest industry is a national economic anchor rooted in hundreds of communities across the country. The Canadian Forest Sector Transformation Task Force was created to chart a path toward a stronger, more competitive, and more resilient sector. That means practical federal action on long-standing priorities: stronger supply chains, better productivity, more homes, and regional resilience. Learn more at FPAC.ca.
After that, they discuss Carney’s recent efforts to reassure Canada’s Jewish community. Both hosts agree the attempt fell short. Matt argues that putting Marc Miller in charge of a new advisory panel feels like a very Trudeau-era response to a serious problem — process instead of action. Jen then raises reports that the Trump administration may consider offering asylum to Canadian Jews. She also notes, to Matt's horror, that he warned months ago that such a possibility could eventually arise. Perhaps, they joke, he manifested it.
This episode is also brought to you by BioCanRx. Nearly half of all Canadians will face a cancer diagnosis in their lives, and Canadian scientists are racing to build better treatments. But it's not just the science — it's the logistics of actually getting it to patients.
BioCanRx is a federally funded, not-for-profit research network that specializes in moving Canadian cancer immunotherapy from the lab to clinical trials here at home. Since 2015, they've funded sixteen trials and treated more than four hundred patients — all with made-in-Canada technology.
So what is immunotherapy? Your immune system eliminates threats every day, including your own cells when they mutate. But sometimes mutating cells are able to evade the immune system — and that's usually when we call them cancer. Immunotherapy supports or modifies your immune system so cancer can't slip past it.
Stay tuned this summer, and visit BioCanRx.com to learn more.
Finally, the hosts check back in on Alberta after what was, by recent standards, a surprisingly quiet week. Probably won't stay that way for long, though. It never does.
Also: Ricky Martin reference!
All that and more in the latest episode of The Line Podcast.
#TheLinePodcast
#MarkCarney
#CanadianPolitics
#CanadaPolitics
#AlbertaPolitics
#MarcMiller
#CanadianJews
#MediaAnalysis
#FederalPolitics
#CurrentAffairs -
In this episode of On The Line, host Jen Gerson sits down with James McLeod of the Canadian Shield Institute to discuss one of the most talked-about — and least understood — concepts in Canadian public policy: digital sovereignty.
This episode of On The Line is brought to you by BioCanRX. Nearly half of all Canadians will get a cancer diagnosis in their lives. Canadian scientists are moving fast to come up with better treatments to help these people. But it’s not just about science, it’s about the logistics of implementing it.
BioCanRx is a federally funded, not-for-profit Canadian research network that specializes in bringing Canadian cancer immunotherapy research from the lab all the way to patients in clinical trials in Canada. Since launching in 2015, they’ve funded 16 clinical trials and treated more than 400 patients across Canada, all with made-in-Canada technologies.
What is immunotherapy? Most immune systems successfully eliminate threats every day –– including our own cells when they mutate in ways they shouldn’t. But when our mutating cells find a way to trick our immune systems, things can start getting out of control. That’s usually when we apply the label "cancer." Immunotherapy is about modifying or supporting your immune system so cancer can't evade it. Stay tuned this summer to learn more about what Canadian research is doing to fight cancer. Go to BioCanRX.com to learn more.
The word “sovereignty” has become a fixture of Canadian political debate in recent years, particularly in response to economic pressure and even annexation rhetoric from U.S. President Donald Trump. But what does sovereignty actually mean in a world where much of Canada’s digital infrastructure, cloud computing, social media, and online services are controlled by American companies and governed by American laws?
McLeod walks Gerson through the realities of living in a digital ecosystem largely built and operated south of the border. They discuss the vulnerabilities that creates for Canada, the limits of what governments can realistically do to regain control, and the difficult trade-offs involved in pursuing greater independence over data, privacy, and critical digital infrastructure.This episode is also brought to you by the Forest Products Association of Canada. Canada’s forest industry is a national economic anchor rooted in hundreds of communities across the country. The Canadian Forest Sector Transformation Task Force was created to chart a path toward a stronger, more competitive, and more resilient sector. That means practical federal action on long-standing priorities: stronger supply chains, better productivity, more homes, and regional resilience. Learn more at FPAC.ca.
The conversation also explores what a Canadian digital sovereignty strategy might actually look like in practice. Can Canada build more domestic capacity? Should it? And what kinds of regulatory and policy tools are available to a middle power trying to assert greater control in a digital world dominated by American technology giants?
It’s a timely discussion about privacy, security, national resilience, and what sovereignty means in the twenty-first century. Check out our main page at ReadTheLine.ca and be sure to like and subscribe. We'll be back on Friday with another episode of The Line Podcast.
#OnTheLine #DigitalSovereignty #Canada #Technology #Privacy #CyberSecurity #DataPrivacy #CanadianPolitics #JenGerson #JamesMcLeod -
In the latest episode of The Line Podcast, recorded on May 29, 2026, Matt Gurney and Jen Gerson begin with discussion of Prime Minister Mark Carney’s trip to New York and the state of Canada-U.S. trade negotiations. Your hosts debate whether Canada has actually surrendered ground in the talks or merely put an opening offer on the table. They also discuss Carney’s popularity. Matt remains eager to see more concrete accomplishments, but he concedes that, at least for now, the prime minister is decisively winning the vibes war.
This episode of The Line Podcast is brought to you by Electro-Federation Canada. Canada’s clean electricity grid gives us a competitive edge in attracting global investment — but to maintain that advantage our system needs to break down barriers and unlock the grid. Aging infrastructure, supply chain constraints, and outdated regulations threaten our ability to expand and modernize the grid — essential components of meeting future capacity needs. Electro-Federation Canada has developed a research-backed roadmap for grid readiness focused on smart policy and regulatory alignment. To learn more, visit MakeTheSwitch.ElectroFed.com.Next, Jen asks Matt to explain the Swedish aircraft Canada is buying, giving him an opportunity to walk listeners through the logic behind the deal. Is this a new line for Canada, or just Carney buying himself the room to buy some U.S. equipment next? That conversation quickly expands into a broader rant about Canada’s inability to simply get important things done. Once again, governments are creating new mechanisms, new processes, and new workarounds to accomplish tasks that functioning countries often manage through their existing institutions.
This episode of The Line Podcast is also brought to you by Dominion Dynamics. Canada has never had true sovereign awareness of our North. Vast parts of our country are a blind spot. And when you can’t see your own territory, you can’t defend it, secure it, or respond when threats emerge. Dominion Dynamics is changing that. Dominion Dynamics is building a sovereign command and control capability that lets Canada and its allies see, respond, and defend across every domain. Dominion is starting in the Arctic, where extreme conditions demand technology no one else can deliver.
Defend the Dominion. Dominion Dynamics.
Learn more at DefendTheDominion.com.
In the final segment, the hosts return to Alberta and the ongoing federalist-versus-separatist debate. They spend considerable time discussing what role, if any, Canadians outside the province should be playing in the conversation. Can outsiders help the federalist cause, or do they risk making matters worse? Matt and Jen don’t agree on every detail, but both recognize that the stakes extend well beyond Alberta itself.
All that and more in the latest episode of The Line Podcast.
#TheLinePodcast
#MarkCarney
#CanadaUSRelations
#TradeNegotiations
#CanadianPolitics
#AlbertaPolitics
#Federalism
#PierrePoilievre
#DefencePolicy
#Geopolitics -
In this episode of On The Line, host Matt Gurney is joined by two guests for conversations about defence, geopolitics, and the changing nature of modern warfare.
This episode of On The Line is brought to you by Dominion Dynamics. Canada has never had true sovereign awareness of our North. Vast parts of our country are a blind spot. And when you can’t see your own territory, you can’t defend it, secure it, or respond when threats emerge. Dominion Dynamics is changing that. Dominion is building a sovereign command and control capability that lets Canada and its allies see, respond, and defend across every domain. We started in the Arctic, where extreme conditions demand technology no one else can deliver.
Threats don’t wait for bureaucracy. They are moving faster than our institutions. Dominion is closing that gap. Speed is now the strategic capability, and Dominion Dynamics is proving you can build capability at the speed of the threat.
Defend the dominion. Dominion Dynamics.
Learn more at DefendTheDominion.com.
First up is Philippe Lagassé of Carleton University, one of Canada’s leading defence analysts, for a discussion about the political and economic realities facing the new government. (You can read Phil's work at his Substack.) They talk about the opportunity Mark Carney may have to make painful but necessary decisions on defence spending, and whether Canadians will remain willing to spend massively on national defence once Donald Trump is no longer dominating the headlines. They also discuss the role domestic industry will need to play in any serious Canadian rearmament effort — and whether the country is actually prepared to invest the money required to make that happen. For now, probably. But for how long? And even after a scandal?
This episode of On The Line is also brought to you by Electro-Federation Canada. Canada’s clean electricity grid gives us a competitive edge in attracting global investment — but to maintain that advantage our system needs to break down barriers and unlock the grid. Aging infrastructure, supply chain constraints, and outdated regulations threaten our ability to expand and modernize the grid — essential components of meeting future capacity needs. Electro-Federation Canada has developed a research-backed roadmap for grid readiness focused on smart policy and regulatory alignment. To learn more, visit MakeTheSwitch.ElectroFed.com.Then Matt is joined by Lazar Berman of The Times of Israel for an update from the war against Hezbollah. Berman discusses how the terror group has increasingly relied on first-person drones to target the IDF, giving relatively cheap technology an outsized impact on the battlefield. He also explains how the Israelis are adapting, what countermeasures are emerging, and what these developments reveal about the future of warfare more broadly.
It’s a pair of conversations about deterrence, industrial capacity, and how quickly military assumptions are changing in a more dangerous world.
This episode of On The Line is also brought to you by ACDC. Canada’s defence industrial base is fragmented. Critical platforms are owned and controlled abroad. That model doesn’t work anymore.
The Alliance of Canadian Defence Companies is rebuilding Canada’s sovereign defence-industrial base. ACDC champions Canadian-owned, Canadian-controlled companies that design, build, sustain, and export next-generation defence systems. Change requires new processes, new policies, and new behaviour. ACDC membership is open to Canadian-controlled defence companies ready to lead that change.
To join, email [email protected].
For more from The Line, check out our main page at ReadTheLine.ca, and don't forget to like and subscribe.
#OnTheLine #CanadaDefence #PhilippeLagasse #MarkCarney #CanadianForces #Israel #Hezbollah #LazarBerman #DroneWarfare #Geopolitics
-
In the latest episode of The Line Podcast, Matt Gurney and Jen Gerson devote the first segment to a full catch-up on the increasingly wild situation unfolding in Alberta. Jen is furious, arguing that five million people — and indeed the entire country — are now being dragged through this largely because Danielle Smith is trying to save her political career. She’s equally angry at parts of the political right that, in her view, are repeating the mistakes the left made during the peak of woke politics: refusing to challenge allies and friends when things start getting out of control. Still, both hosts agree that now that the fight is fully underway, the issues can at least finally be debated openly. Jen states plainly, with Matt’s agreement, that The Line holds an explicitly federalist position. You've been warned.
This episode of The Line Podcast is brought to you by Electro-Federation Canada. Canada’s clean electricity grid gives us a competitive edge in attracting global investment — but to maintain that advantage our system needs to break down barriers and unlock the grid. Aging infrastructure, supply chain constraints, and outdated regulations threaten our ability to expand and modernize the grid — essential components of meeting future capacity needs. Electro-Federation Canada has developed a research-backed roadmap for grid readiness focused on smart policy and regulatory alignment. To learn more, visit MakeTheSwitch.ElectroFed.com.In the second segment, the hosts discuss some of the major personalities shaping events, including Smith, Naheed Nenshi, Jason Kenney, and Pierre Poilievre. Jen also flags a particular political group that listeners should keep an eye on. Matt spends part of the segment stress-testing two of Jen’s arguments, offering an interpretation of Smith’s conduct that could potentially prove constructive, and sketching out a possible good-news scenario that Jen reluctantly entertains. He doesn't think he sold her.
This episode of The Line Podcast is also brought to you by Dominion Dynamics. Canada has never had true sovereign awareness of our North. Vast parts of our country are a blind spot. And when you can’t see your own territory, you can’t defend it, secure it, or respond when threats emerge. Dominion Dynamics is changing that. Dominion Dynamics is building a sovereign command and control capability that lets Canada and its allies see, respond, and defend across every domain. Dominion is starting in the Arctic, where extreme conditions demand technology no one else can deliver.Defend the Dominion. Dominion Dynamics.
Learn more at DefendTheDominion.com.
To close, your hosts briefly revisit last week’s CBC controversy, which has only become worse as additional targets — including retired RCMP officers — have emerged. The CBC says it has halted funding and launched a review, but neither host believes that will resolve the problem. Both agree that media organizations tend to forget everything they know about how the media works the moment they become the story themselves. Speaking of institutional trouble, Matt closes by asking, only half jokingly, whether the CRTC could perhaps avoid declaring war on the United States for at least the next month or so. If it's not too much trouble.
All that and more on the latest episode of The Line Podcast. Check us out at ReadTheLine.ca, and God help us all.
#TheLinePodcast
#AlbertaPolitics
#DanielleSmith
#CanadianPolitics
#NaheedNenshi
#PierrePoilievre
#CBC
#CRTC
#CanadianMedia
#CanadaUSRelations -
In this episode of On The Line, host Jen Gerson speaks with Flavio Volpe, president of the Automotive Parts Manufacturers’ Association, about the increasingly tense state of Canada-U.S. trade relations.
This episode of On The Line is brought to you by Dominion Dynamics. Canada has never had true sovereign awareness of our North. Vast parts of our country are a blind spot. And when you can’t see your own territory, you can’t defend it, secure it, or respond when threats emerge. Dominion Dynamics is changing that. Dominion is building a sovereign command and control capability that lets Canada and its allies see, respond, and defend across every domain. We started in the Arctic, where extreme conditions demand technology no one else can deliver.
Threats don’t wait for bureaucracy. They are moving faster than our institutions. Dominion is closing that gap. Speed is now the strategic capability, and Dominion Dynamics is proving you can build capability at the speed of the threat.
Defend the dominion. Dominion Dynamics.
Learn more at DefendTheDominion.com.
They discuss the ongoing negotiations around CUSMA, what could happen if the United States ultimately decides to walk away from the deal, and why Canada doesn’t have the luxury of negotiating these disputes loudly or publicly. Volpe explains the deeply integrated nature of the North American auto sector, and why a full reshoring of American automotive manufacturing would be far more disruptive — and far less realistic — than many politicians seem to believe.
This episode of On The Line is also brought to you by Electro-Federation Canada. Canada’s clean electricity grid gives us a competitive edge in attracting global investment — but to maintain that advantage our system needs to break down barriers and unlock the grid. Aging infrastructure, supply chain constraints, and outdated regulations threaten our ability to expand and modernize the grid — essential components of meeting future capacity needs. Electro-Federation Canada has developed a research-backed roadmap for grid readiness focused on smart policy and regulatory alignment. To learn more, visit MakeTheSwitch.ElectroFed.com.
The conversation also touches on the political theatre surrounding the talks, including recent comments from Howard Lutnick suggesting that Canada “sucks” at negotiating. Gerson asks Volpe directly: is there any truth to that criticism, or are Canadians underestimating the constraints they’re operating under?
It’s a practical discussion about trade, manufacturing, political leverage, and the realities of economic interdependence between Canada and the United States.
This episode of On The Line is also brought to you by ACDC. Canada’s defence industrial base is fragmented. Critical platforms are owned and controlled abroad. That model doesn’t work anymore.
The Alliance of Canadian Defence Companies is rebuilding Canada’s sovereign defence-industrial base. ACDC champions Canadian-owned, Canadian-controlled companies that design, build, sustain, and export next-generation defence systems. Change requires new processes, new policies, and new behaviour. ACDC membership is open to Canadian-controlled defence companies ready to lead that change.
To join, email [email protected].
#OnTheLine #Canada #US #Trade #CUSMA #USMCA #Auto #FlavioVolpe #CanadaPolitics #JenGerson
-
In the latest episode of The Line Podcast, recorded on May 15, 2026, your hosts Matt Gurney and Jen Gerson start with Alberta. The new energy agreement has been signed. They think it'll help, but only to an extent, because what's happening in Jen's province isn't primarily economic. It's cultural. And a pipeline can't fix that.
This episode of The Line Podcast is brought to you by Electro-Federation Canada. Canada’s clean electricity grid gives us a competitive edge in attracting global investment — but to maintain that advantage our system needs to break down barriers and unlock the grid. Aging infrastructure, supply chain constraints, and outdated regulations threaten our ability to expand and modernize the grid — essential components of meeting future capacity needs. Electro-Federation Canada has developed a research-backed roadmap for grid readiness focused on smart policy and regulatory alignment. To learn more, visit MakeTheSwitch.ElectroFed.com.Next, they talk a bizarre story where the CBC (and APTN) chose to bankroll a so-called comedy group that was trying to "satirize" prominent people from Canada's heterodox right-wing, such as Frances Widdowson and Lindsay Shepherd. Your hosts walk you through the huge number of concerns here, but focus mostly on the CBC's role. This is not a good look for the public broadcaster, and guess what? The people your hosts have spoken among CBC's journalists get that. Very much so. Why didn't their bosses see the danger?
This episode of The Line Podcast is also brought to you by Dominion Dynamics. Canada has never had true sovereign awareness of our North. Vast parts of our country are a blind spot. And when you can’t see your own territory, you can’t defend it, secure it, or respond when threats emerge. Dominion Dynamics is changing that. Dominion Dynamics is building a sovereign command and control capability that lets Canada and its allies see, respond, and defend across every domain. Dominion is starting in the Arctic, where extreme conditions demand technology no one else can deliver.
Defend the Dominion. Dominion Dynamics.
Learn more at DefendTheDominion.com.
To wrap, they chat briefly about a few overlapping stories that suggest that the world has started to tune Donald Trump out. Matt wonders if that's going to work out — how will Americans, particularly MAGA Americans, end up getting what they want: a world that doesn't rely on American leadership, because we've tuned them out entirely?
All that, and more, in the latest episode of The Line Podcast. Happy Victoria Day! We'll talk to you next week.
#TheLinePodcast
#AlbertaPolitics
#CanadianPolitics
#CBC
#DonaldTrump
#CanadaEnergy
#PipelinePolitics
#MAGA
#MediaCriticism
#CanadaUSRelations -
Today on On The Line, host Matt Gurney is joined by two guests for conversations about Canadian preparedness — both military and medical.
This episode of On The Line is brought to you by Dominion Dynamics. Canada has never had true sovereign awareness of our North. Vast parts of our country are a blind spot. And when you can’t see your own territory, you can’t defend it, secure it, or respond when threats emerge. Dominion Dynamics is changing that. Dominion is building a sovereign command and control capability that lets Canada and its allies see, respond, and defend across every domain. We started in the Arctic, where extreme conditions demand technology no one else can deliver.
Threats don’t wait for bureaucracy. They are moving faster than our institutions. Dominion is closing that gap. Speed is now the strategic capability, and Dominion Dynamics is proving you can build capability at the speed of the threat.
Defend the dominion. Dominion Dynamics.
Learn more at DefendTheDominion.com.
First up is Richard Shimooka of the Macdonald-Laurier Institute and The Hub for a discussion about the future of Canadian defence. What does the military actually need to rebuild itself after decades of neglect? Why will restoring real capability take the better part of a decade, even under ideal conditions? They also discuss what Canada’s defence industrial strategy needs to get right if the country is serious about rearmament, and why the costs involved may soon collide with political and fiscal reality.
This episode of On The Line is also brought to you by Electro-Federation Canada. Canada’s clean electricity grid gives us a competitive edge in attracting global investment — but to maintain that advantage our system needs to break down barriers and unlock the grid. Aging infrastructure, supply chain constraints, and outdated regulations threaten our ability to expand and modernize the grid — essential components of meeting future capacity needs. Electro-Federation Canada has developed a research-backed roadmap for grid readiness focused on smart policy and regulatory alignment. To learn more, visit MakeTheSwitch.ElectroFed.com.Then Matt is joined by Dr. Isaac Bogoch of Toronto General Hospital and the University Health Network for a rapid primer on Hanta virus, the recent cruise ship evacuation that drew headlines, and why evacuation isn’t the same thing as quarantine. They also reflect on the lessons of COVID, what Canada learned, what it failed to learn, and what public-health systems need to get right the next time a serious infectious disease threat emerges.
This episode of On The Line is also brought to you by ACDC. Canada’s defence industrial base is fragmented. Critical platforms are owned and controlled abroad. That model doesn’t work anymore.
The Alliance of Canadian Defence Companies is rebuilding Canada’s sovereign defence-industrial base. ACDC champions Canadian-owned, Canadian-controlled companies that design, build, sustain, and export next-generation defence systems. Change requires new processes, new policies, and new behaviour. ACDC membership is open to Canadian-controlled defence companies ready to lead that change.
To join, email [email protected].
All that, plus the usual On The Line conversations about risk, preparedness, and the systems Canadians rely on more than they often realize. Oh. And shotguns.
#OnTheLine #CanadaDefence #RichardShimooka #CanadianForces #Military #HantaVirus #IsaacBogoch #PublicHealth #CanadaPolitics #MattGurney
- もっと表示する
